UCLA-ISAP investigators are involved in several projects concerning cannabis use and cannabis policy. See below for some of the recent research UCLA-ISAP has produced in this area.
Research Publications
Padwa, H., Huang, D., Mooney, L., Grella, C.E., Urada, D., Bell, D.S., Bass, B., Boustead, A.E. (2022). Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in Electronic Health Records: a case control study from an academic health system in a medical marijuana state. Substance Abuse Treatment, Prevention, and Policy 17(36).
Wolitzky-Taylor, K., Glasner, S., Tanner, A., Ghahremani, D.G., London, E.D. (2022). Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept. Behaviour Research and Therapy 150:104032.
Karno, M.P., Rawson, R., Rogers, B., Spear, S., Grella, C., Mooney, L.J., Saitz, R., Kagan, B., Glasner, S. (2020). Effect of screening, brief intervention, and referral to treatment for unhealthy alcohol and other drug use in mental health treatment settings: a randomized controlled trial. Addiction 116(1):159-169.
Young, S.D., Padwa, H., Bonar, E.E. (2019). Social big data as a tool for understanding and predicting the impact of cannabis legalization. Frontiers in Public Health, 274.
Mooney, L.J., Zhu, Y., Yoo, C., Valdez, J., Moino, K. Liao, J.Y., Hser, Y. (2018). Reduction in cannabis use and functional status in physical health, mental health, and cognition. Journal of Neuroimmune Pharmacology 13(4):479-487.
Hser, Y-I., Mooney, L.J., Huang, D., Zhu, Y., Tomko, R.L., McClure, E., Chou, C-P., Gray, K.M. (2017). Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. Journal of Substance Abuse Treatment 81:53-58.
Gray, K.M., Sonne, S.C., McClure, E.A., Ghitza, U.E., Matthews, A.G., McRae-Clark, A.L., Carroll, K.M., Potter, J.S., Wiest, K., Mooney, L.J., Hasson, A., Walsh, S.L, Lofwall, M.R., Babalonis, S., Lindblad, R.W., Sparenborg, S., Wahle, A., King, J.S., Baker, N.L., Tomko, R.L., Haynes, L.F., Vandrew, R.G., Levin, F.R. (2017). A randomized-placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug and Alcohol Dependence 177:249-257.
Wolitzky-Taylor, K., McBeth, J., Guillot, C.R., Stone, M.D., Kirkpatrick, MG., Zvolensky, M.J., Buckner, J.D., & Leventhal, A.M. (2016). Transdiagnostic processes linking anxiety symptoms and substance use problems among adolescents. Journal of Addictive Diseases, 35(4):266=277.
McClure, E.A., Sonne, S.C., Winhusen, T., Carroll, K.M., Ghitza, U.E., McRae-Clark, A.L., Matthews, A.G., Sharma, G., Van Veldhuisen, P., Vandrew, R.G., Levin, F.R., Weiss, R.D., Lindblad, R., Allen, C., Mooney, L.J., Haynes, L., Brigham, G.S., Sparenborg, S., Hasson, A.L., Gray, K.M. (2014). Achieving Cannabis cessation—evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemporary Clinical Trials 39(2):211-223.